Venture capital firm General Catalyst announced it closed $8 billion in new capital, including $6 billion for its latest fund, Fund XII, and $2 billion in separately managed accounts.
The $8 billion will be used to boost the firm's investments across various sectors, including defense and intelligence, climate and energy, AI, industrials, and healthcare and fintech.
The company will distribute...
Viome Life Sciences announced a $25 million internal Series D and the appointment of its new chief operating officer, Kal Raman.
Khosla Ventures, Marc Benioff, Bold Capital WRG Ventures and others participated in the round.
Raman joins Viome as COO after previously holding the position of senior vice president of non-media business, marketing and retail technology at Amazon and chief digital...
Ben Robbins, general partner at GV (Google Ventures), sat down with MobiHealthNews to discuss how the multibillion-dollar venture firm invests in digital health companies, AI's place in healthcare and how government fits into the sector.
MobiHealthNews: How do you decide which companies to invest in? You have a background in psychiatry. Does that influence what captures your attention in a...
The perspective on seeking investment varies company by company. Still, a common theme exists that it is necessary to ensure knowledge of the market and the actual value of one's technology and that the company's cash runway does not disappear before more funding is secured.
Brigham Hyde, CEO of Atropos Health, discussed with MobiHealthNews the crucial internal and external factors companies must...
Pharma companies are seeing the value of digital health, and are creating departments focused on developing, scaling and investing in platforms that use technology to enhance life sciences R&D, better assist providers and engage with patients.
Sonny Shergill, vice president of commercial digital health at AstraZeneca, sat down with MobiHealthNews to discuss the evolution of its strategy...
Matt Cybulsky, practice leader for healthcare AI, value-based care and product innovation at LBMC, has studied and analyzed the digital health market for years and advised companies on scaling and profitability as funding landscapes have shifted.
Cybulsky sat down with MobiHealthNews to discuss strategies for digital health investment and AI's role in improving both business profitability and...
If the momentum of investment continues, this year could surpass year-end totals seen in 2019 and 2023 ($8.2B and $10.7B, respectively), two years that can serve as comparable periods outside the pandemic, according to Rock Health's H1 2024 digital health funding report released this week.
Digital health startups in the U.S. raised $5.7 billion across 266 deals in the first half of 2024.
Seed,...
Healthcare data and analytics and tech-enabled services will be the sectors most impacted by generative AI, according to a survey by investment firm GSR Ventures.
The survey, which included responses from more than 40 healthcare technology venture capitalists, found that over 71% believe ChatGAPT/GenAI changes their investment strategy "somewhat" or "a little." In contrast, 12% say it affects...
Return on investment and clinical validation will be the most significant indicators for success for digital health companies in 2023, according to a survey by investment firm GSR Ventures.
The survey, which included responses from more than 50 investors, found that more than 94% deemed ROI to be "important" or "very important" to a digital health company's success, and 79% said clinical evidence...
Digital health companies scored $57.2 billion in funding worldwide last year across 2,930 deals, increasing 79% from 2020, according to CB Insights' State of Digital Health 2021 Report.
"Funding in all geographies hit record levels in 2021, fueled by the growing need to provide digital solutions and delivery models to patients during the pandemic," the report's authors wrote.
However, the U.S....
